Back to Results
First PageMeta Content
Chemistry / Syndromes / Piperazines / Pharmacology / Eli Lilly and Company / Neuroleptic malignant syndrome / Serotonin syndrome / Olanzapine / Antipsychotic / Atypical antipsychotics / Psychiatry / Medicine


Annals of General Hospital Psychiatry BioMed Central Open Access
Add to Reading List

Document Date: 1984-07-12 19:45:00

Open Document

File Size: 207,58 KB

Share Result on Facebook

City

Barcelona / /

Company

MEDLINE / Paplos KG / BioMed Central Ltd. / Phillips LC / Havaki-Kontaxaki BJ / Christodoulou NG / /

/

Facility

Arch Gen Psychiatry / University of Athens / Eginition Hospital / /

IndustryTerm

aminergic systems / /

MedicalCondition

Incoordination / classical serotonin syndrome / mental retardation / treatment refractory schizophrenia / Myoclonus / Hyperreflexia / JE / Schizophrenia / Possible neuroleptic malignant syndrome / Toxic serotonin syndrome / malignant syndrome / olanzapine-induced neuroleptic malignant syndrome / fever / Tremor / Atypical neuroleptic malignant syndrome / serotonin syndrome / Diarrhea / neuroleptic malignant syndrome / restlessness / MS / syndrome / Olanzapine-associated neuroleptic malignant syndrome / /

Organization

Department of Psychiatry / Eginition Hospital / University of Athens / /

Person

Van Hauser / Konstantinos G Paplos / Med Clin / George N Christodoulou / Beata J Havaki-kontaxaki / Ann Pharmacother / Paul Nurse / /

Position

author / VP / Nurse / scientist / General / Corresponding author / /

Product

venlafaxine / Olanzapine / Clozapine / /

RadioStation

Am 1993 / /

URL

http /

SocialTag